rais po follow bax analyst day took place
today nyc increas convict bax revenu ep growth outlook drive
higher po revenu growth main area focu analyst day
provid new long rang plan lrp revenu margin ep free cash flow
divis highlight opportun grow market innov
expand adjac express high convict growth acceler
deliv promis well compani follow new
guidanc seem conserv mani level inde exit meet
high convict bax abil gener close ep growth next
five year revenu growth compound-annual-growth-rate name
healthcar deliv type growth especi bax lower risk profil
view believ maintain premium new po
assum trade ep prior po base
ep ep estim assum much buy-back either
bax new lrp call revenu growth ep growth next
year guidanc clearli conserv view exclud
exclud buy-back exclud revenu risk adjust
model also assum headwind gener competit annual btw
next year assum gener
could rais anoth debt suggest could access close
liquid despit financi flexibl bax lrp assum
contribut balanc sheet even dividend spend off-set
stock option dilut calcul close liquid
assum buy-back annual next five year bax ep compound-annual-growth-rate would
move assum guidanc convict bax growth
outlook high given view bax capabl capabl
much readi leverag two year ago
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
baxter manufactur product use deliveri
fluid drug patient across
continuum care includ iv
steril solut administr set premix
drug drug-reconstitut system iv nutrit
product infus pump inhal
servic relat pharmaci compound
drug formul packag technolog
believ baxter opportun grow ep
higher end peer given compani
margin expans opportun lever
balanc sheet expect put balanc
sheet work set stage
improv revenu growth later
rate stock buy
term new year analyst day import disclosur
